TIDE clinical trial opens at Hôpital Gustave Roussy

LATTICE MEDICAL unveils yet another milestone in its TIDE clinical trial in Paris!

We are delighted to announce the opening of the fifth centre in our TIDE clinical trial: Hôpital Gustave Roussy in Paris, Europe’s leading cancer centre.

As a reminder, the Lille University Hospital, the Strasbourg University Hospital, the Paris Public Hospitals and the Ramsay Santé Clinique de l’Atlantique are also open to the recruitment of eligible patients 🏥

Gustave Roussy Hospital:

• Address: 114 rue Edouard Vaillant, 94800 Villejuif, France
• Secretariat telephone number: 01.42.11.42.11
• Dr Nicolas Leymarie : 01.69.10.30.90

The TIDE clinical trial concerns the MATTISSE bioprosthesis for breast reconstruction after total mastectomy following breast cancer.

If you are interested in our clinical trial or would like to find out more about our MATTISSE bioprosthesis, please do not hesitate to contact the Lille University Hospital at the following addresses:

• flavien.gautron@chu-lille.fr
• gaelle.guyot@chu-lille.fr

A questionnaire is also available on our website.

You can find out more about the TIDE clinical trial in our updated press release here https://www.lattice-medical.com/wp-content/uploads/2024/05/maj-cp-etude-tide-france-16-05.pdf